Perspective Therapeutics, Inc. (CATX) vs Neuronetics, Inc. (STIM)
Perspective Therapeutics, Inc. and Neuronetics, Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. is the larger, with a market value of $285.4M against $214.9M — 1.3× the size. Neuronetics, Inc. grew revenue faster over the last twelve months: 39.6% against −66.9%. Neuronetics, Inc. has the higher net margin (−19.6% vs −28,468.0%) and the higher return on invested capital (−24.6% vs −88.4%). Across the 18 metrics below, Neuronetics, Inc. leads on 13 and Perspective Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | CATX | STIM | Medical Devices median |
|---|---|---|---|
| Gross margin | 100.00% | 49.12% | 56.01% |
| Operating margin | (30,619.07%) | (14.74%) | (15.03%) |
| Net margin | (28,467.97%) | (19.62%) | (20.40%) |
| Free cash flow margin | (29,630.07%) | (7.24%) | (7.24%) |
| Return on equity | (39.50%) | (114.52%) | (15.32%) |
| Return on assets | (33.14%) | (22.87%) | (19.72%) |
| Return on invested capital | (88.41%) | (24.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack